BMS645737(651744-16-0)
- Name: BMS645737
- Synonyms:5-isopropyl-6-(5-methyl-1,3,4-oxadiazol-2-yl)-N-(2-methyl-1H-pyrrolo[2,3-b]pyridin-5-yl)pyrrolo[2,1-f][1,2,4]triazin-4-amine;UNII-86H6HFH34L;
- Molecular Formula:C20H20N8O
- Molecular Weight:388.43
- CAS Registry Number:651744-16-0
- EINECS:
- Melting Point:
- Water Solubility:
Other Product
- 1144076-41-4/Urea, N-[4-(4-Methyl-1-piperazinyl)phenyl]-N'-[4-[4-(8-oxa-3-azabicyclo[3.2.1]oct-3-yl)-1-(2,2,2-trifluoroethyl)-1H-pyrazolo[3,4-d]pyriMidin-6-yl]phenyl]-, CF3COOH salt
- 1144072-40-1/Urea, N-[4-(4-methyl-1-piperazinyl)phenyl]-N'-[4-[4-(8-oxa-3-azabicyclo[3.2.1]oct-3-yl)-1-(2,2,2-trifluoroethyl)-1H-pyrazolo[3,4-d]pyrimidin-6-yl]phenyl]-
- 677297-55-1/Phenol, 3,3'-(2,4-diamino-6,7-pteridinediyl)bis-, 2 HCL salt
- 677298-35-0/Phenol, 3,3'-(2,4-diamino-6,7-pteridinediyl)bis-, H2SO4 slat
- 885616-78-4/PI-540
- 885617-20-9/1-Piperazineethanol, 4-[[2-(3-hydroxyphenyl)-4-(4-morpholinyl)thieno[3,2-d]pyrimidin-6-yl]methyl]-
- 618385-01-6/Vorapaxar
- 705260-08-8/Vorapaxar Sulfate
- 592542-59-1/(2-METHOXY-5-[2-(2,4,6-TRIMETHOXY-PHENYL)-ETHENESULFONYLMETHYL]-PHENYLAMINO)-ACETIC ACID, SODIUM SALT
- 592542-60-4/Glycine, N-[2-methoxy-5-[[[(1E)-2-(2,4,6-trimethoxyphenyl)ethenyl]sulfonyl]methyl]phenyl]-, sodium Slat
- 1100353-03-4/2H-1-Benzopyran-3-carboxamide, N-(3-imidazo[1,2-a]pyridin-2-ylphenyl)-8-methoxy-2-oxo-
- 1170689-68-5/2H-1-Benzopyran-3-carboxamide, 8-hydroxy-N-(3-imidazo[1,2-a]pyridin-2-ylphenyl)-2-oxo-
- 797035-11-1/BETA-SECRETASE INHIBITOR IV
- 388063-46-5/N1-((2S,3R)-1-(3,5-difluorophenyl)-3-hydroxy-4-((3-iodobenzyl)amino)butan-2-yl)-5-methyl-N3,N3-dipropylisophthalamide
- 946420-45-7/4-Pyridinecarboxamide, N-[(1S,2R)-2-amino-3-fluoro-1-(phenylmethyl)propyl]-2-[[[(1S,2S)-2-methylcyclopropyl]methyl]amino]-6-[methyl[(1-methylethyl)sulfonyl]amino]-, CF3COOH salt
- 860311-93-9/4-Pyridinecarboxamide, N-[(1S,2R)-2-amino-3-fluoro-1-(phenylmethyl)propyl]-2-[[[(1S,2S)-2-methylcyclopropyl]methyl]amino]-6-[methyl[(1-methylethyl)sulfonyl]amino]-
- 452342-67-5/GW788388
- 452342-37-9/GW-6604
- 356068-94-5/Toceranib
- 651744-16-0/BMS645737
- 1000669-72-6/[4-[2-(1H-Indazol-3-yl)ethenyl]phenyl]-1-piperazinylmethanone
- 897016-82-9/KX2-391
- 1038395-65-1/KX2-391
- 451492-95-8/MP-412
- 451493-31-5/2-Propenamide, N-[4-[(3-chloro-4-fluorophenyl)amino]-7-[3-methyl-3-(4-methyl-1-piperazinyl)-1-butyn-1-yl]-6-quinazolinyl]-, 4-methylbenzenesulfonate (1:2)
- 162760-96-5/CYCLOHEXANECARBOXAMIDE, N-[2-[4-(2-METHOXYPHENYL)-1-PIPERAZINYL]ETHYL]-N-2-PYRIDINYL-, HYDROCHLORIDE (1:3)
- 843653-25-8/2H-1-Benzopyran-5-carboxamide, 3-[cyclobutyl[3-(5-fluoro-1H-indol-3-yl)propyl]amino]-8-fluoro-3,4-dihydro-, (3R)-
- 843653-28-1/2H-1-Benzopyran-5-carboxamide, 3-[cyclobutyl[3-(5-fluoro-1H-indol-3-yl)propyl]amino]-8-fluoro-3,4-dihydro-, hydrochloride (1:1), (3R)-
- 944341-44-0/5-Pyrimidinecarboxaldehyde, 4-amino-6-[[1-[(3-fluorophenyl)methyl]-1H-indazol-5-yl]amino]-, O-(2-methoxyethyl)oxime, [C(E)]-
- 943972-07-4/1H-Pyrazolo[3,4-d]pyrimidin-4-amine, 3-[2-[(2-chlorophenyl)methyl]-1H-benzimidazol-6-yl]-1-[trans-4-[4-(3-methoxypropyl)-1-piperazinyl]cyclohexyl]-